CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression

Yichong Ning1,2, Chunqing Wang1,2,3, Xin Liu1,2,4

  • 1State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, 410081, Hunan, China.

Abstract

Insights

Dysfunctional p53 protein is linked to cancer. This study identifies a CK2/CCDC106/p53 signaling pathway promoting breast and cervical cancer progression, offering a potential new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • p53 protein dysfunction is a critical driver of cancer development.
  • CCDC106 protein has been implicated in reducing p53 stability and is associated with lung cancer.
  • The specific roles of CCDC106 in other cancer types and its upstream regulatory mechanisms remain largely unexplored.

Purpose of the Study:

  • To investigate the role of CCDC106 in breast and cervical cancers.
  • To identify upstream regulators of CCDC106.
  • To elucidate the molecular mechanisms by which CCDC106 influences cancer progression and p53 stability.

Main Methods:

  • In vitro kinase assays and Western blotting were used to analyze protein phosphorylation.
  • Co-immunoprecipitation and GST-pulldown assays were employed to determine protein interactions.
  • Functional assays included cell viability, apoptosis, colony formation, migration, and invasion assays. In vivo studies utilized a xenograft mouse model.

Main Results:

  • CCDC106 knockdown stabilized p53, enhancing apoptosis and suppressing proliferation, migration, and invasion in cervical and breast cancer cells with wild-type p53 (wtp53).
  • Overexpression of CCDC106 had opposing effects. CCDC106 did not affect p53-mutant cancer cells.
  • CK2 phosphorylates CCDC106 at Ser-130 and Ser-147, which is crucial for its interaction with p53 and nuclear localization, respectively. Inhibition of this phosphorylation abrogated CCDC106's oncogenic functions.
  • Wild-type CCDC106 promoted tumor growth and p53 degradation in vivo. Suppression of CCDC106 increased sensitivity to the CK2 inhibitor CX-4945.

Conclusions:

  • A novel CK2/CCDC106/p53 signaling axis was identified, playing a significant role in the progression of breast and cervical cancers.
  • This signaling pathway represents a potential therapeutic target for treating these cancers.
  • Targeting CCDC106 or its upstream regulators may enhance the efficacy of existing cancer therapies.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
171.5K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.4K